Q2 2021 Holdings
Filed 2021-08-16 | 95 holdings | $534.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| BeiGene Ltd(ONC) | SPONSORED ADR | 07725L102 | $262.3M | 764,188 | 49.1% |
| Arcus Biosciences Inc.(RCUS) | COM | 03969F109 | $57.3M | 2,084,883 | 10.7% |
| ArgenX SE(ARGX) | SPONSORED ADR | 04016X101 | $51.5M | 170,926 | 9.6% |
| Cytokinetics Inc.(CYTK) | COM NEW | 23282W605 | $41.6M | 2,100,000 | 7.8% |
| Biomea Fusion Inc.(BMEA) | COM | 09077A106 | $32.6M | 2,088,405 | 6.1% |
| Cullinan Oncology Inc.(CGEM) | COM | 230031106 | $27.7M | 1,074,082 | 5.2% |
| Black Diamond Therapeutics Inc.(BDTX) | COM | 09203E105 | $24.6M | 2,014,858 | 4.6% |
| Biomarin Pharmaceutical Inc.(BMRN) | COM | 09061G101 | $20.9M | 250,000 | 3.9% |
| Cabaletta Bio Inc.(CABA) | COM | 12674W109 | $13.8M | 1,603,361 | 2.6% |
| Mirati Therapeutics Inc.(MRTXEUR) | COM | 60468T105 | $323.1K | 2,000,000 | 0.1% |
| Springworks Therapeutics Inc. | COM | 85205L107 | $171.1K | 2,075,905 | 0.0% |
| iTeos Therapeutics Inc.(5E7) | COM | 46565G104 | $111.5K | 4,345,016 | 0.0% |
| Revolution Medicines Inc.(RVMD) | COM | 76155X100 | $110.6K | 3,484,264 | 0.0% |
| PMV Pharmaceuticals Inc.(PMVP) | COM | 69353Y103 | $77.5K | 2,268,236 | 0.0% |
| Rocket Pharmaceuticals Inc.(RCKT) | COM | 77313F106 | $64.9K | 1,466,051 | 0.0% |
| Seagen Inc.(SGENUSD) | COM | 81181C104 | $63.2K | 400,000 | 0.0% |
| Sage Therapeutics Inc.(SG7) | COM | 78667J108 | $62.2K | 1,094,000 | 0.0% |
| Silverback Therapeutics Inc.(SPRY) | COM | 82835W108 | $51.8K | 1,675,377 | 0.0% |
| Relay Therapeutics Inc.(RLAY) | COM | 75943R102 | $47.4K | 1,294,132 | 0.0% |
| Ideaya Biosciences Inc.(IDYA) | COM | 45166A102 | $46.2K | 2,202,812 | 0.0% |
| Marinus Pharmaceuticals Inc.(MRNS*) | COM NEW | 56854Q200 | $43.1K | 2,400,000 | 0.0% |
| DBV Technologies SA | SPONSORED ADR | 23306J101 | $41.2K | 7,534,598 | 0.0% |
| Connect Biopharma Holdings Ltd. | ADS | 207523101 | $40.6K | 2,081,323 | 0.0% |
| Nuvation Bio Inc.(NUVB) | COM CL A | 67080N101 | $40.4K | 4,341,009 | 0.0% |
| Merus NV | COM | N5749R100 | $40.0K | 1,900,000 | 0.0% |
| Syndax Pharmaceuticals Inc.(SNDX) | COM | 87164F105 | $39.3K | 2,287,782 | 0.0% |
| Anaptys Bio Inc.(ANAB) | COM | 032724106 | $33.7K | 1,300,000 | 0.0% |
| Nurix Therapeutics Inc.(NRIX) | COM | 67080M103 | $32.5K | 1,224,892 | 0.0% |
| Aligos Therapeutics Inc. | COM | 01626L105 | $31.1K | 1,526,048 | 0.0% |
| BioAtla Inc.(BCAB) | COM | 09077B104 | $29.1K | 686,347 | 0.0% |
| Avidity Biosciences Inc.(RNA) | COM NEW | 05370A108 | $27.7K | 1,121,327 | 0.0% |
| Day One Biopharmaceuticals Inc.(DAWN) | COM | 23954D109 | $27.1K | 1,189,943 | 0.0% |
| Amarin Corp PLC | SPONS ADR NEW | 023111206 | $26.3K | 6,000,000 | 0.0% |
| Therapeutics Acquisition Corp | COM CL A | 88339T103 | $25.7K | 2,500,000 | 0.0% |
| Passage Bio Inc. | COM | 702712100 | $25.5K | 1,928,315 | 0.0% |
| Kinnate Biopharma Inc. | COM | 49705R105 | $24.8K | 1,065,939 | 0.0% |
| Kadmon Holdings Inc.(KDMN) | COM | 48283N106 | $24.0K | 6,205,882 | 0.0% |
| Amicus Therapeutics Inc.(FOLD) | COM | 03152W109 | $22.4K | 2,325,000 | 0.0% |
| GH Research PLC(GHRS) | ORDINARY SHARES | G3855L106 | $22.0K | 1,013,399 | 0.0% |
| Agenus Inc.(AGENEUR) | COM NEW | 00847G705 | $22.0K | 4,000,000 | 0.0% |
| Kura Oncology Inc.(KURA) | COM | 50127T109 | $21.9K | 1,050,289 | 0.0% |
| Gossamer Bio Inc.(GOSS) | COM | 38341P102 | $20.8K | 2,562,358 | 0.0% |
| Akero Therapeutics Inc.(AKRO) | COM | 00973Y108 | $20.6K | 831,495 | 0.0% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $20.1K | 904,227 | 0.0% |
| Mereo Biopharma Group PLC(MREO) | ADS | 589492107 | $19.7K | 6,226,673 | 0.0% |
| Essa Pharma Inc.(EPIEUR) | COM | 29668H708 | $19.6K | 687,000 | 0.0% |
| Odonate Therapeutics Inc. | COM | 676079106 | $19.6K | 5,607,086 | 0.0% |
| Codiak Biosciences Inc.(32W) | COM | 192010106 | $19.1K | 1,030,065 | 0.0% |
| Atreca Inc.(BCELUSD) | CL A COM | 04965G109 | $18.8K | 2,202,333 | 0.0% |
| Cerevel Therapeutics Holding Inc.(CERE1EUR) | COM CL A | 15678U128 | $18.3K | 714,500 | 0.0% |